CARLSBAD, Calif.--(BUSINESS WIRE)--Sept. 15, 2006--The Immune Response Corporation (OTCBB:IMNR), an immuno-pharmaceutical company developing products to treat autoimmune and infectious diseases, announced today that James L. Foght, Ph.D., has joined the company's Board of Directors. Dr. Foght is Managing Partner of Foght Enterprises, L.L.C., which is focused on international business advisory services. He is also Managing Director and a member of the investment committee of Vector Later-Stage Equity Funds, specializing in investments in the life sciences.
